FDA OKs first drug to treat Alzheimers agitation TwitteRx
."These symptoms are leading causes of assisted living or nursing home placement and have been associated with accelerated disease progression," Farchione said.
Brexpiprazole was approved by the FDA in 2015 as an adjunctive therapy to antidepressants for adults with major depressive disorder and for adults withApproval of the supplemental application for brexpiprazole for agitation associated with AD dementia was based on results of two randomized, double-blind, placebo-controlled studies.
The recommended starting dosage for the treatment of agitation associated with AD dementia is 0.5 mg once daily on days 1 to 7; it was increased to 1 mg once daily on days 8 through 14 and then to the recommended target dose of 2 mg once daily. The dosage can be increased to the maximum recommended daily dosage of 3 mg once daily after at least 14 days, depending on clinical response and tolerability.
The most common side effects of brexpiprazole in patients with agitation associated with AD dementia includeThe drug includes a boxed warning for medications in this class that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.For more Medscape Neurology news, join us on
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Chicago protesters demanding access to FDA-approved Alzheimer's drugsThe Alzheimer's Association said every day without access to FDA-approved drugs, approximately 2,000 people reach a stage of the disease where they are no longer eligible for treatment.
Read more »
Japan's Otsuka Pharma gets FDA approval for Alzheimer's agitation drugThe U.S. Food and Drug Administration approved Otsuka Pharmaceutical's brexpiprazole to treat agitation in patients with Alzheimer's on Thursday, making it the first approved drug for the indication, the company said in a statement.
Read more »
FDA approves ALS treatment for patients with genetic diseaseThe FDA has fast-tracked a new ALS treatment for patients whose disease is genetic. Patients who have been getting the injections report a slowing of their disease progression and even renewed strength.
Read more »
FDA Approves Gene-Hacked SausagesThe FDA just gave the OK for a new genetically-modified pig sausage to enter the food supply. Gene-hacked sausages for all!
Read more »
FDA panel backs first over-the-counter birth control pill in USThe committee's recommendation means the agency is likely to formally approve the drug this summer.
Read more »
2023 Land Rover Defender 130 First Edition P400 First Drive: Going Big!It’s designed to keep on going when the road runs out. But Land Rover’s biggest Defender is also a brilliant long-distance highway cruiser.
Read more »